|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Effects of liraglutide (NN2211), a long-acting GLP-1 analogue, on glycaemic control and bodyweight in subjects with Type 2 diabetes显示文摘 | Feinglos MN Saad MF Pi-sunyer FX | 2005 | Diabete Med2005，22，8： | 1 |
| 2 | Effects of liraglutide(NN2211),a long-acting GLP-1 analogue,on glycaemic control and bodyweight in subjects with type 2 diabetes显示文摘 | Feinglos MN Saad MF Pi-Sunyer FX | 2005 | Diabetic Medicine2005，22，8： | 1 |
| 3 | Therapy of type 2 diabetes, cardio- vascular death, and the UGDP显示文摘 | Feinglos MN Bethel MA | 1999 | American heart journal1999，138，5： | 1 |
| 4 | Stress and diabetes mel- litus 显示文摘 | Surw it RS Schneider MS Feinglos MN | 1992 | Diabetes Care1992，15，10： | 1 |
| 5 | Gestational diabetemellitus显示文摘 | Setji TL Brown AJ Feinglos MN | 2005 | Clin Diabet[J]2005，23，1： | 1 |
| 6 | Effects of liraglutide (NN2211),a long-acting GLP-1 analogue,on glycaemic control and bodyweight in subjects with Type 2 diabetes显示文摘 | Feinglos MN Saad MF Pi-Sunyer FX | 2005 | Diabet Med2005，22，8： | 1 |
| 7 | ' Insulin' allergy due to zinc 显示文摘 | Feinglos MN Jegasothy BV | 1979 | Lancet1979，20，1： | 1 |
| 8 | Basal insulin thempy in type 2 diabetes显示文摘 | Bethel MA Feinglos MN | 2005 | Am Board Fam Pract2005，18，3： | 1 |
| 9 | Effect of initial combination therapy with sitagliptin, a dipeptidyl peptidase-4 inhibitor, and metformin on glycemic control in patients with type 2 diabetes显示文摘 | Goldstein BJ Feinglos MN Lunceford JK | 2007 | Diabetes Care2007，30，： | 1 |
| 10 | Effect of initial combination therapy with sitagliptin,a dipeptidyl peptidase-4 inhibitor,and metformin on glycemic control in patients with type 2 diabetes显示文摘 | Goldstein BJ Feinglos MN Lunceford JK | | 0，，8： | 1 |
| 11 | Basal insulin therapy in type 2 diabetes显示文摘 | Bethel MA Feinglos MN | 2005 | Am Board Fam Pract2005，18，3： | 1 |
| 12 | Basal insulin therapy in type 2 diabetes显示文摘 | Bethel MA Feinglos MN | 2005 | Am Board Fam pract2005，18，3： | 1 |
| 13 | Drug-induced hyperglycemia显示文摘 | Luna B Feinglos MN | | 0，，16： | 1 |
| 14 | Drug-induced hyperglycemia 显示文摘 | Luna B Feinglos MN | 2001 | JAMA2001，286，16： | 1 |
| 15 | Effect of initial combination therapy with sitagliptin, a dipeptidyl peptidase-4 inhibitor, and metformin on glycemic control in patients with type 2 diabetes显示文摘 | Goldstein B J Feinglos MN Lunceford JK | 2007 | Diabetes Care2007，30，8： | 1 |
| 16 | Effect of initial combination therapy with sitagliptin, a dipeptidyl peptidase 4 inhibitor, and metformin on glycemic control in patients with type 2 diabetes显示文摘 | Goldstein BJ Feinglos MN Lunceford JK | 2007 | Diabetes Care2007，30，： | 1 |
| 17 | Effects of liraglutide (NN2211) , a long-acting GLP-1 analogue, on glycaemic control and body weight in subjects with type 2 diabetes显示文摘 | Feinglos MN Saad MF Pi-Stmyer FX | 2005 | Diabet Med2005，22，8： | 1 |
| 18 | Combination insulin and sulfonylurea therapy in insulin-requiring type 2 diabetes mellitus显示文摘 | Feinglos MN Thacker CR Lobaugh B | 1998 | Diabetes Res Clin Pract1998，39，3： | 1 |
| 19 | Protease inhibitor-induced diabetic complications:ncidence, management and prevention显示文摘 | Lien LF Feinglos MN | 2005 | Drug Saf2005，28，3： | 1 |
| 20 | Effect of initial combination therapy with sitagliptin, a dipeptidyl peptidase-4 inhibitor, and mefformin on glycemic control in patients with type 2 diabetes显示文摘 | Goldstein BJ Feinglos MN Lunceford JK | 2007 | Diabetes Care2007，30，8： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员